Joshua A Kazam Allogene Therapeutics, Inc. (ALLO) insider trading activity

ALLO Quotes by TradingView

Joshua A Kazam is of Allogene Therapeutics, Inc.. Currently has a direct ownership of 303,063 shares of ALLO, which is worth approximately $633,401. The most recent transaction as insider was on Jun 15, 2022, when has been sold 44,178 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 303K
0% 3M change
0% 12M change
Total Value Held $633,401

Joshua A Kazam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2022
BUY
Grant, award, or other acquisition
-
44,178 Added 12.72%
303,063 Common Stock
Mar 07 2022
SELL
Bona fide gift
-
412,618 Reduced 61.45%
258,885 Common Stock
Mar 07 2022
BUY
Other acquisition or disposition
-
412,618 Added 38.06%
671,503 Common Stock
Jan 12 2022
BUY
Open market or private purchase
$189,000 $12.6 p/Share
15,000 Added 5.48%
258,885 Common Stock
Jun 11 2021
SELL
Bona fide gift
-
500,000 Reduced 67.21%
243,885 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
16,498 Added 2.17%
743,885 Common Stock

Also insider at

KRON
Kronos Bio, Inc. Healthcare
TSIBW
Tishman Speyer Innovation Corp. II ETFs
Director
LTCH
Latch, Inc. Technology
JAK

Joshua A Kazam

South San Francisco, CA

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO